Searched for
CINACALCET SALES
A big opportunity is beginning to unlock for us in the US: Cipla'Inhaler opportunity can add to Cipla’s position in lung medicines.'- Cipla Q3 results preview: Profit likely to rise 25-27%The company will report its quarterly numbers on Wednesday.
- Stock pick of the week: What has made Cipla a favourite of analystsDue to the recent price correction, the risk-reward ratio of Cipla has turned favourable. Despite the tough environment, the company is tak...
- Cipla Q1 results: Profit likely to fall 14%, US sales may take a hitCentrum expects South Africa and RoW also to remain under pressure in terms of growth and R&D spend to remain higher around 8 per cent of s...
- Stocks in the news: DHFL, IndiGo, Aurobindo Pharma, Religare and GTPL HathwayNCLT dismissed a petition by HDFC to initiate insolvency proceedings against RHC Holding.
Load More